Should You Buy Vaxart Inc (VXRT) Stock After it Is Lower By 2.70% in a Week?

Vaxart Inc (VXRT) stock is lower by 2.70% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Vaxart Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VXRT!

See Full VXRT Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With VXRT Stock Today?

Vaxart Inc (VXRT) stock is flat 0% while the S&P 500 is lower by -0.06% as of 4:00 PM on Wednesday, Sep 27. VXRT is unmoved $0.00 from the previous closing price of $0.72 on volume of 1,053 shares. Over the past year the S&P 500 has gained 17.13% while VXRT is lower by -66.82%. VXRT lost -$0.76 per share in the over the last 12 months. To screen for more stocks like Vaxart Inc click here.

More About Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. Click Here to get the full Stock Report for Vaxart Inc stock.